Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Harmatz

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
Behavioral Biology|February 1, 1975
Postisolation aggression and olfactory cuesP Harmatz, R C Boelkins, S Kessler
Nutrition (Burbank, Los Angeles County, Calif.)|July 1, 1993
Burn severity, copper dose, and plasma ceruloplasmin in burned children during total parenteral nutritionJ J Cunningham, M Leffell, P Harmatz
Behavior Genetics|July 1, 1975
The genetics of pheromonally mediated aggression in mice. I. Strain difference in the capacity of male urinary odors to elicit aggressionS Kessler, P Harmatz, S A Gerling
Journal of Cellular Physiology|July 1, 1989
Prolactin is transported across the epithelium of the jejunum and ileum of the suckling ratP A Gonnella, P Harmatz, W A Walker
Metabolism: Clinical and Experimental|August 1, 1995
Elevated plasma ceruloplasmin in insulin-dependent diabetes mellitus: evidence for increased oxidative stress as a variable complicationJ Cunningham, M Leffell, P Mearkle, et al.
Journal of Clinical Ultrasound : JCU|November 1, 1984
Sonographic demonstration of reversible portal vein thrombosis following splenectomy in an adolescentN Papanicolaou, P Harmatz, J F Simeone, et al.
The New England Journal of Medicine|February 11, 1982
Successful treatment of primary amebic meningoencephalitisJ S Seidel, P Harmatz, G S Visvesvara, et al.
Acta Paediatrica (Oslo, Norway : 1992). Supplement|May 18, 2005
Pharmacokinetic profile of recombinant human N-acetylgalactosamine 4-sulphatase enzyme replacement therapy in patients with mucopolysaccharidosis VI (Maroteaux-Lamy syndrome): a phase I/II studyP Harmatz, W G Kramer, J J Hopwood, et al.
Journal of Clinical Monitoring and Computing|February 13, 2003
Validation of the Natus CO-Stat End Tidal Breath Analyzer in children and adultsH J Vreman, R J Wong, P Harmatz, et al.
Human Mutation|February 20, 2004
Mutational analysis of mucopolysaccharidosis type VI patients undergoing a trial of enzyme replacement therapyL Karageorgos, P Harmatz, J Simon, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Behavioral Biology|February 1, 1975
Postisolation aggression and olfactory cuesP Harmatz, R C Boelkins, S Kessler
Nutrition (Burbank, Los Angeles County, Calif.)|July 1, 1993
Burn severity, copper dose, and plasma ceruloplasmin in burned children during total parenteral nutritionJ J Cunningham, M Leffell, P Harmatz
Behavior Genetics|July 1, 1975
The genetics of pheromonally mediated aggression in mice. I. Strain difference in the capacity of male urinary odors to elicit aggressionS Kessler, P Harmatz, S A Gerling
Journal of Cellular Physiology|July 1, 1989
Prolactin is transported across the epithelium of the jejunum and ileum of the suckling ratP A Gonnella, P Harmatz, W A Walker
Metabolism: Clinical and Experimental|August 1, 1995
Elevated plasma ceruloplasmin in insulin-dependent diabetes mellitus: evidence for increased oxidative stress as a variable complicationJ Cunningham, M Leffell, P Mearkle, et al.
Journal of Clinical Ultrasound : JCU|November 1, 1984
Sonographic demonstration of reversible portal vein thrombosis following splenectomy in an adolescentN Papanicolaou, P Harmatz, J F Simeone, et al.
The New England Journal of Medicine|February 11, 1982
Successful treatment of primary amebic meningoencephalitisJ S Seidel, P Harmatz, G S Visvesvara, et al.
Acta Paediatrica (Oslo, Norway : 1992). Supplement|May 18, 2005
Pharmacokinetic profile of recombinant human N-acetylgalactosamine 4-sulphatase enzyme replacement therapy in patients with mucopolysaccharidosis VI (Maroteaux-Lamy syndrome): a phase I/II studyP Harmatz, W G Kramer, J J Hopwood, et al.
Journal of Clinical Monitoring and Computing|February 13, 2003
Validation of the Natus CO-Stat End Tidal Breath Analyzer in children and adultsH J Vreman, R J Wong, P Harmatz, et al.
Human Mutation|February 20, 2004
Mutational analysis of mucopolysaccharidosis type VI patients undergoing a trial of enzyme replacement therapyL Karageorgos, P Harmatz, J Simon, et al.
Pageof 3